Načítá se...

Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study

BACKGROUND: Several studies have suggested a survival benefit of neoadjuvant therapy (NAT) for pancreatic ductal adenocarcinoma (PDAC) in the pancreatic head. Data concerning NAT for PDAC located in pancreatic body or tail are lacking. METHODS: Post hoc analysis of an international multicenter retro...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Surg Oncol
Hlavní autoři: Lof, Sanne, Korrel, Maarten, van Hilst, Jony, Alseidi, Adnan, Balzano, Gianpaolo, Boggi, Ugo, Butturini, Giovanni, Casadei, Riccardo, Dokmak, Safi, Edwin, Bjørn, Falconi, Massimo, Keck, Tobias, Malleo, Giuseppe, de Pastena, Matteo, Tomazic, Ales, Wilmink, Hanneke, Zerbi, Alessandro, Besselink, Marc G., Abu Hilal, Mohammed
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer International Publishing 2019
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7210228/
https://ncbi.nlm.nih.gov/pubmed/31848815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-019-08137-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!